Immunohistology analyses found that HERV-W ENV is expressed in postmortem tissues of lungs, gut, heart, brain parenchyma, and nasal mucosa from acute COVID-19 patients and the sites where HERV-W were found correlated to the clinical manifestations observed in the donor patients (Charvet et al., 2023). The gene discussed is ERVW-1; the disease is COVID-19.